Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

Fetal Tissue, Stem Cells & Bioethics

136 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
136 results
Fetal Tissue, Stem Cells & Bioethics

The Treatment of Human Embryos Created through IVF: The U.S. and 15 Selected Countries’ Regulations

This paper examines the present status of in vitro fertilization laws, regulations, and guidelines in a sampling of countries. While countries like Italy, Germany, and Poland have regulated IVF in a way that attempts to protect human life in its earliest stages, the United States has virtually no IVF regulations regarding the treatment of human embryos, allowing for the creation, destruction, and indefinite freezing of countless embryonic human beings.

Amanda Stirone Mansfield, J.D.
November 22, 2024
Please login to bookmarkClose
Fetal Tissue, Stem Cells & Bioethics

IVF Industry Regulation in the United States: Changes Are Needed to Protect Embryonic Children and their Families

Federal, state, and professional regulations provide a very limited patchwork of protections for IVF patients, let alone their unborn children created through the procedure. There is a need for improved regulation of the IVF industry, both federally and at the state level.

Fetal Tissue, Stem Cells & Bioethics

A Fact-Free Campaign Against Parents and Unborn Children in Alabama

Recently, Alabama passed a new law that grants immunity from both civil and criminal liability to IVF clinics for destroying human embryos, without parents’ consent and for any reason. This came in the wake of the Alabama supreme court ruling that parents can file suit when, without their consent and against their interests, a medical facility causes the death one or more of their frozen embryos. In this On Point, Richard Doerflinger clarifies the facts of the case and Alabama law, as well as countering misinformation.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

On February 19, 2024, CLI associate scholar Mary E. Harned, J.D., submitted an amicus brief on behalf of CLI to the Constitutional Court of Ecuador. This brief was written in support of three provisions of Ecuador’s Organic Law Regulating the Voluntary Interruption of Pregnancy: (1) a requirement that ultrasounds be performed prior to abortion decisions, (2) a 12-week gestational age limit on abortion, and (3) a prohibition on the commodification of post-abortion fetal remains. Following is CLI’s amicus brief reproduced in full.

Fetal Tissue, Stem Cells & Bioethics

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

On January 25, 2024, CLI submitted a public comment to the CDC regarding newly proposed modifications related to data collection and reporting from assisted reproductive technology programs and modifications to data validation procedures. In light of the fact that none of these proposed changes recognized the inherent value and dignity of nascent human beings created from ART programs, including IVF, CLI took the opportunity to encourage the CDC to do so and to consider limiting, reporting, or regulating "the number of living embryos destined for research and destruction."

Fetal Tissue, Stem Cells & Bioethics

Stopping the Pain and Saving Lives: Successful Treatments for Sickle Cell Disease

The U.S. Food and Drug Administration (FDA) recently approved not just one, but two new gene therapies for sickle cell disease. The success of adult stem cell therapies continues to demonstrate that the progress of science and medicine need not rely on ethically compromised research and treatment approaches.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Human Embryonic Stem Cell Research 25 Years On

Twenty-five years ago, scientists first isolated human embryonic stem cells (hESCs). Shortly after this development, the use of these stem cells in medical research had become a major public policy controversy in the United States.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Charlotte Lozier Scholars Discuss Bioethical Challenges and Exploiting Nascent Human Beings

On Friday, September 22, 2023, Dr. David Prentice and Dr. Tara Sander Lee presented at Faith and Law's Friday Forum session on Capitol Hill.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image